Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Scott Berkowitz

Concepts (377)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rivaroxaban
108
2023
211
11.330
 Why?
Factor Xa Inhibitors
69
2022
138
5.860
 Why?
Anticoagulants
73
2022
547
4.920
 Why?
Stroke
67
2022
1019
4.650
 Why?
Aspirin
47
2023
324
4.550
 Why?
Atrial Fibrillation
43
2021
324
4.110
 Why?
Warfarin
39
2021
135
3.700
 Why?
Platelet Aggregation Inhibitors
46
2023
400
3.640
 Why?
Peripheral Arterial Disease
26
2023
380
3.530
 Why?
Hemorrhage
59
2023
618
3.290
 Why?
Intracranial Embolism
17
2021
29
2.590
 Why?
Morpholines
27
2021
102
2.450
 Why?
Venous Thromboembolism
16
2022
231
2.430
 Why?
Thiophenes
26
2021
108
2.410
 Why?
Embolism
17
2021
43
1.760
 Why?
Drug Monitoring
7
2021
184
1.660
 Why?
Arthroplasty, Replacement, Hip
9
2020
109
1.640
 Why?
Risk Adjustment
3
2020
75
1.540
 Why?
Double-Blind Method
60
2021
1662
1.530
 Why?
Vitamin K
15
2017
42
1.160
 Why?
Myocardial Infarction
18
2023
927
1.150
 Why?
Aged
108
2022
19094
1.060
 Why?
Arthroplasty, Replacement, Knee
11
2020
246
1.050
 Why?
Endovascular Procedures
5
2022
268
1.050
 Why?
Lower Extremity
11
2022
335
1.040
 Why?
Thrombosis
4
2022
297
1.040
 Why?
Brain Ischemia
9
2022
299
1.000
 Why?
Treatment Outcome
69
2022
9089
0.960
 Why?
Drug Therapy, Combination
28
2023
954
0.920
 Why?
Enoxaparin
12
2020
52
0.870
 Why?
Thromboembolism
8
2020
93
0.850
 Why?
Heparin
14
2003
222
0.850
 Why?
Coronary Disease
12
2021
347
0.840
 Why?
Fibrinolytic Agents
10
2022
233
0.820
 Why?
Coronary Artery Disease
8
2021
607
0.820
 Why?
Thrombolytic Therapy
6
2017
117
0.780
 Why?
Middle Aged
82
2021
26757
0.760
 Why?
Brain Infarction
5
2021
22
0.750
 Why?
Venous Thrombosis
10
2020
140
0.740
 Why?
Male
115
2022
55579
0.730
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
8
2002
22
0.700
 Why?
Thrombocytopenia
11
2003
177
0.690
 Why?
Female
112
2022
59507
0.680
 Why?
Humans
161
2023
114757
0.670
 Why?
Postoperative Complications
6
2021
2127
0.670
 Why?
Ischemia
7
2023
362
0.610
 Why?
Administration, Oral
23
2021
731
0.590
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.580
 Why?
Risk Factors
39
2022
8627
0.560
 Why?
Blood Coagulation
9
2020
217
0.560
 Why?
Risk Assessment
17
2021
2973
0.550
 Why?
Cardiovascular Diseases
9
2021
1727
0.520
 Why?
Angioplasty, Balloon, Coronary
8
2003
146
0.500
 Why?
Blood Transfusion
4
2014
276
0.480
 Why?
Prothrombin Time
5
2020
34
0.470
 Why?
Immunoglobulin Fab Fragments
7
2002
69
0.470
 Why?
Dose-Response Relationship, Drug
16
2021
1846
0.450
 Why?
Pulmonary Embolism
8
2020
181
0.440
 Why?
Biomarkers, Pharmacological
3
2020
26
0.400
 Why?
Drug Administration Schedule
15
2021
718
0.400
 Why?
Cerebral Hemorrhage
3
2021
96
0.390
 Why?
Surgical Wound Infection
1
2014
248
0.380
 Why?
Recurrence
11
2021
936
0.340
 Why?
Secondary Prevention
6
2020
222
0.330
 Why?
Plaque, Atherosclerotic
2
2020
44
0.320
 Why?
Antibodies, Monoclonal
8
2002
1270
0.320
 Why?
Aged, 80 and over
22
2021
6350
0.320
 Why?
Heart Valve Prosthesis Implantation
2
2001
175
0.320
 Why?
Vascular Surgical Procedures
2
2021
257
0.310
 Why?
Models, Statistical
3
2020
604
0.300
 Why?
Prognosis
6
2021
3334
0.300
 Why?
Angina, Unstable
4
2003
72
0.290
 Why?
Incidence
11
2021
2312
0.290
 Why?
Gastrointestinal Hemorrhage
2
2019
102
0.280
 Why?
Vascular Diseases
2
2021
230
0.270
 Why?
Time Factors
16
2021
6124
0.260
 Why?
Platelet Aggregation
3
2002
94
0.260
 Why?
Atherosclerosis
2
2019
342
0.260
 Why?
Kaplan-Meier Estimate
9
2021
815
0.260
 Why?
Aortic Valve Insufficiency
2
2016
45
0.240
 Why?
Follow-Up Studies
13
2020
4420
0.240
 Why?
Diabetes Mellitus
5
2021
904
0.240
 Why?
Mitral Valve Insufficiency
2
2016
63
0.240
 Why?
Azetidines
4
2005
31
0.230
 Why?
International Normalized Ratio
5
2018
45
0.230
 Why?
Anti-Arrhythmia Agents
2
2015
106
0.230
 Why?
Internationality
6
2021
144
0.230
 Why?
Proportional Hazards Models
8
2021
1080
0.220
 Why?
Randomized Controlled Trials as Topic
10
2019
1214
0.220
 Why?
Intention to Treat Analysis
7
2021
68
0.220
 Why?
Arteries
2
2022
247
0.220
 Why?
Postoperative Care
2
2003
219
0.220
 Why?
Chemoprevention
2
2020
88
0.210
 Why?
Myocardial Ischemia
3
2000
234
0.210
 Why?
Antifibrinolytic Agents
2
2014
50
0.210
 Why?
Platelet Function Tests
2
2002
24
0.210
 Why?
Acute Coronary Syndrome
2
2019
254
0.210
 Why?
Withholding Treatment
2
2021
68
0.210
 Why?
Renal Insufficiency
2
2021
136
0.210
 Why?
Drug Carriers
1
2003
112
0.210
 Why?
Multimorbidity
1
2022
34
0.200
 Why?
von Willebrand Factor
4
1992
56
0.200
 Why?
Echocardiography, Transesophageal
2
2019
89
0.200
 Why?
Carotid Artery Diseases
2
2019
57
0.200
 Why?
Electrocardiography
3
2001
562
0.200
 Why?
Drug-Eluting Stents
1
2021
62
0.190
 Why?
Drug Substitution
3
2021
46
0.190
 Why?
Heart Valves
1
2001
41
0.180
 Why?
Clinical Trials as Topic
6
2016
935
0.180
 Why?
Therapeutic Index
1
2020
2
0.180
 Why?
Paclitaxel
1
2021
190
0.180
 Why?
Intracranial Arteriosclerosis
1
2020
8
0.180
 Why?
Troponin T
1
2020
49
0.170
 Why?
Kidney
2
2017
1184
0.170
 Why?
Point-of-Care Systems
2
2014
136
0.170
 Why?
Comorbidity
6
2021
1449
0.160
 Why?
Thrombophlebitis
2
1997
8
0.160
 Why?
Tyrosine
1
2000
215
0.160
 Why?
Intracranial Hemorrhages
3
2019
76
0.160
 Why?
Cardiomegaly
1
2020
157
0.160
 Why?
Prospective Studies
12
2021
6217
0.150
 Why?
Peptide Fragments
5
2003
668
0.150
 Why?
Polypharmacy
2
2016
74
0.150
 Why?
Heart Failure
6
2021
1952
0.150
 Why?
Coronary Thrombosis
3
2016
25
0.150
 Why?
Brain
2
2020
2374
0.150
 Why?
Partial Thromboplastin Time
4
2014
51
0.150
 Why?
Foramen Ovale, Patent
1
2018
45
0.150
 Why?
Body Mass Index
3
2021
1958
0.150
 Why?
Antigens
1
1999
318
0.150
 Why?
Antibodies, Monoclonal, Humanized
2
2020
664
0.150
 Why?
Heart Diseases
1
2021
330
0.150
 Why?
Neoplasms
3
2020
2105
0.140
 Why?
Ischemic Attack, Transient
1
2018
62
0.140
 Why?
Aorta, Thoracic
1
2019
254
0.140
 Why?
Overweight
1
2021
471
0.140
 Why?
Surgery, Oral
1
1996
6
0.140
 Why?
Orthodontic Appliances
1
1996
10
0.140
 Why?
Calcium Channel Blockers
1
2017
115
0.140
 Why?
Drug Discovery
2
2015
124
0.140
 Why?
Prevalence
5
2021
2249
0.140
 Why?
Cleft Lip
1
1996
32
0.130
 Why?
Cognitive Dysfunction
1
2020
284
0.130
 Why?
Cleft Palate
1
1996
46
0.130
 Why?
Angioplasty, Balloon
1
1997
88
0.130
 Why?
Clinical Trials, Phase III as Topic
4
2019
82
0.130
 Why?
Digoxin
1
2015
26
0.120
 Why?
Multivariate Analysis
6
2016
1435
0.120
 Why?
Biomarkers
3
2020
3416
0.120
 Why?
Factor X
1
2014
24
0.120
 Why?
Prothrombin
1
2014
22
0.120
 Why?
Factor IX
1
2014
34
0.120
 Why?
Factor VII
1
2014
26
0.120
 Why?
Adult
16
2020
30548
0.120
 Why?
Amiodarone
1
2014
23
0.120
 Why?
Blood Coagulation Factors
1
2014
44
0.120
 Why?
Cognition Disorders
1
2018
477
0.120
 Why?
Severity of Illness Index
5
2021
2539
0.120
 Why?
Defibrillators, Implantable
1
2017
286
0.110
 Why?
Cardiovascular Agents
1
2015
125
0.110
 Why?
Models, Biological
2
2019
1630
0.110
 Why?
Mortality
3
2021
288
0.110
 Why?
Recombinant Proteins
4
2015
1233
0.110
 Why?
Sex Factors
4
2021
1717
0.110
 Why?
Elective Surgical Procedures
1
2014
151
0.110
 Why?
Hematoma
1
2013
49
0.100
 Why?
Arthroplasty, Replacement, Ankle
1
2012
26
0.100
 Why?
von Willebrand Diseases
2
1990
11
0.100
 Why?
Hirudins
2
2003
46
0.100
 Why?
Retrospective Studies
10
2018
12515
0.100
 Why?
Heparin, Low-Molecular-Weight
2
2005
27
0.100
 Why?
Quality of Life
1
2022
2358
0.090
 Why?
Survival Rate
4
2020
1642
0.090
 Why?
Percutaneous Coronary Intervention
1
2016
444
0.090
 Why?
Peptides
4
2002
849
0.090
 Why?
Continuity of Patient Care
1
2013
254
0.090
 Why?
Age Factors
4
2018
2890
0.090
 Why?
Latin America
2
2021
69
0.090
 Why?
Hospitalization
2
2016
1752
0.090
 Why?
Obesity, Morbid
1
2013
197
0.090
 Why?
Prodrugs
3
2005
42
0.090
 Why?
Acute Disease
5
2021
912
0.090
 Why?
Factor Xa
3
2015
32
0.090
 Why?
Magnetic Resonance Imaging
4
2021
3039
0.080
 Why?
Chemical and Drug Induced Liver Injury
1
2011
123
0.080
 Why?
Single-Blind Method
2
2020
258
0.080
 Why?
Predictive Value of Tests
3
2021
1796
0.080
 Why?
Tissue Plasminogen Activator
3
2022
225
0.080
 Why?
Sialic Acids
1
1988
7
0.080
 Why?
Thrombin
2
2014
139
0.080
 Why?
Obesity
1
2021
2513
0.080
 Why?
Pancreatic Elastase
1
1988
65
0.080
 Why?
Calpain
1
1988
53
0.080
 Why?
Hypertension
1
2016
1059
0.080
 Why?
Logistic Models
4
2021
1843
0.070
 Why?
Peptide Hydrolases
1
1988
105
0.070
 Why?
Platelet Transfusion
2
1999
64
0.070
 Why?
Platelet Count
2
1998
81
0.070
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2021
299
0.070
 Why?
Drug Approval
2
2015
78
0.070
 Why?
Adolescent
8
2020
17808
0.070
 Why?
Cohort Studies
3
2022
4901
0.070
 Why?
Magnetic Resonance Angiography
2
2019
219
0.070
 Why?
United States Food and Drug Administration
2
2015
172
0.070
 Why?
International Cooperation
2
2018
172
0.070
 Why?
Drug Combinations
2
2019
286
0.070
 Why?
Preoperative Care
2
2020
317
0.070
 Why?
Europe
2
2019
336
0.070
 Why?
Infusions, Intravenous
2
1998
372
0.070
 Why?
Injections, Subcutaneous
3
2010
134
0.060
 Why?
Combined Modality Therapy
2
2020
1122
0.060
 Why?
Purinergic P2Y Receptor Antagonists
2
2018
62
0.060
 Why?
Creatinine
2
2017
424
0.060
 Why?
United States
5
2019
12176
0.060
 Why?
Benzylamines
4
2005
39
0.060
 Why?
Forecasting
2
2013
331
0.060
 Why?
Child
5
2020
18352
0.060
 Why?
Safety
3
2000
297
0.060
 Why?
Pharmacokinetics
1
2003
25
0.060
 Why?
Body Weight
2
1998
869
0.060
 Why?
Caprylates
1
2003
19
0.050
 Why?
Cause of Death
2
2016
362
0.050
 Why?
Myocardial Revascularization
2
2000
67
0.050
 Why?
Numbers Needed To Treat
1
2021
8
0.050
 Why?
Multicenter Studies as Topic
2
2000
249
0.050
 Why?
Infant
3
2020
7935
0.050
 Why?
Mobility Limitation
1
2022
60
0.050
 Why?
Injections, Intravenous
2
2000
201
0.050
 Why?
Pipecolic Acids
1
2001
23
0.050
 Why?
Child, Preschool
3
2020
9079
0.050
 Why?
Intermittent Claudication
1
2022
108
0.050
 Why?
Hirudin Therapy
1
2000
2
0.050
 Why?
Antithrombins
1
2000
49
0.040
 Why?
Antineoplastic Agents, Phytogenic
1
2021
181
0.040
 Why?
Patient Safety
2
2013
278
0.040
 Why?
Streptokinase
2
1997
10
0.040
 Why?
Stents
2
2002
475
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
59
0.040
 Why?
Acetates
1
2000
95
0.040
 Why?
Heart Valve Diseases
1
2001
161
0.040
 Why?
Heart Atria
1
2020
108
0.040
 Why?
Cerebral Angiography
1
2019
109
0.040
 Why?
Drug Dosage Calculations
1
2019
21
0.040
 Why?
Global Health
1
2021
288
0.040
 Why?
Monitoring, Physiologic
1
2001
248
0.040
 Why?
Pyridones
1
2020
123
0.040
 Why?
Health Status Disparities
1
2021
201
0.040
 Why?
MEDLINE
1
2018
22
0.040
 Why?
Blood Pressure
2
2016
1530
0.040
 Why?
Diagnostic Tests, Routine
1
2019
87
0.040
 Why?
Sex Distribution
2
2015
335
0.040
 Why?
Disease-Free Survival
1
2020
623
0.040
 Why?
Coronary Artery Bypass
1
2000
198
0.040
 Why?
Arginine
2
2015
236
0.040
 Why?
Australia
1
2019
207
0.040
 Why?
Computed Tomography Angiography
1
2019
97
0.040
 Why?
Walking
1
2022
422
0.040
 Why?
Antibody Formation
1
1999
267
0.040
 Why?
Dermatan Sulfate
1
1997
3
0.040
 Why?
Placebos
1
1998
198
0.040
 Why?
Infant, Newborn
2
2020
5035
0.040
 Why?
Catheters, Indwelling
1
1998
79
0.040
 Why?
Heparitin Sulfate
1
1997
39
0.040
 Why?
Chondroitin Sulfates
1
1997
33
0.040
 Why?
Alanine Transaminase
2
2011
141
0.040
 Why?
Statistics, Nonparametric
1
2018
386
0.040
 Why?
Ligands
1
1999
565
0.040
 Why?
Hemodilution
1
1997
10
0.040
 Why?
Diltiazem
1
2017
23
0.040
 Why?
Verapamil
1
2017
32
0.040
 Why?
Blood Transfusion, Autologous
1
1997
19
0.040
 Why?
Hip Prosthesis
1
1997
33
0.040
 Why?
Postoperative Period
2
2013
289
0.040
 Why?
Glomerular Filtration Rate
1
2020
604
0.040
 Why?
Recombinant Fusion Proteins
1
2000
617
0.040
 Why?
Knee Prosthesis
1
1997
15
0.030
 Why?
Gingivoplasty
1
1996
1
0.030
 Why?
Alveoloplasty
1
1996
2
0.030
 Why?
Pyrazoles
1
2020
364
0.030
 Why?
Morbidity
1
2017
277
0.030
 Why?
Lip
1
1996
20
0.030
 Why?
China
1
2017
162
0.030
 Why?
Maxillofacial Development
1
1996
18
0.030
 Why?
Kidney Function Tests
1
2017
140
0.030
 Why?
Survival Analysis
1
2000
1218
0.030
 Why?
Clinical Decision-Making
1
2019
268
0.030
 Why?
Cardiopulmonary Bypass
1
1997
176
0.030
 Why?
Thrombophilia
1
2016
66
0.030
 Why?
Blood Platelets
1
1998
351
0.030
 Why?
Bone Transplantation
1
1996
98
0.030
 Why?
Geography
1
2016
180
0.030
 Why?
Anxiety Disorders
1
2018
303
0.030
 Why?
Depressive Disorder
1
2018
332
0.030
 Why?
Federal Government
1
2015
26
0.030
 Why?
Death, Sudden
1
2015
27
0.030
 Why?
Government Regulation
1
2015
46
0.030
 Why?
Animals
5
2013
31762
0.030
 Why?
Drug Industry
1
2015
104
0.030
 Why?
Area Under Curve
1
2014
275
0.030
 Why?
Chronic Disease
1
2019
1590
0.030
 Why?
Congresses as Topic
1
2015
196
0.030
 Why?
Healthy Volunteers
1
2014
197
0.030
 Why?
Risk
1
2016
815
0.030
 Why?
North America
1
2014
257
0.030
 Why?
Hemarthrosis
1
2012
11
0.030
 Why?
Piperazines
1
2015
311
0.030
 Why?
Neurotransmitter Agents
1
2013
76
0.030
 Why?
Algorithms
1
1999
1468
0.030
 Why?
Comparative Effectiveness Research
1
2013
130
0.030
 Why?
Plasma
1
2014
210
0.030
 Why?
Aortic Valve Stenosis
1
2016
272
0.030
 Why?
Clinical Protocols
1
2013
232
0.020
 Why?
Evidence-Based Medicine
1
2016
667
0.020
 Why?
Heart Rate
1
2015
704
0.020
 Why?
Cognition
1
2018
989
0.020
 Why?
Validation Studies as Topic
1
2011
23
0.020
 Why?
Acenocoumarol
1
2010
1
0.020
 Why?
Bilirubin
1
2011
88
0.020
 Why?
Liver Function Tests
1
2011
103
0.020
 Why?
Adverse Drug Reaction Reporting Systems
1
2011
68
0.020
 Why?
Alkaline Phosphatase
1
2011
143
0.020
 Why?
Patient Selection
1
2014
641
0.020
 Why?
Drug Design
1
2011
151
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2269
0.020
 Why?
Syndrome
2
2002
334
0.020
 Why?
Phlebography
1
2009
34
0.020
 Why?
Biomedical Research
1
2015
585
0.020
 Why?
Registries
1
2016
1759
0.020
 Why?
Macromolecular Substances
1
1988
200
0.020
 Why?
Molecular Targeted Therapy
1
2011
347
0.020
 Why?
Coronary Angiography
2
2001
304
0.020
 Why?
Amino Acid Sequence
2
1990
1988
0.020
 Why?
Structure-Activity Relationship
1
1988
503
0.020
 Why?
Research Design
1
2013
931
0.020
 Why?
Risk Reduction Behavior
1
2009
201
0.020
 Why?
Molecular Structure
1
1988
438
0.020
 Why?
In Vitro Techniques
1
1988
1013
0.020
 Why?
Epitopes
1
1988
435
0.020
 Why?
Analysis of Variance
1
2009
1226
0.020
 Why?
Models, Molecular
1
2011
1378
0.020
 Why?
Blotting, Western
1
1988
1151
0.020
 Why?
Cross-Sectional Studies
1
2016
4409
0.020
 Why?
Sensitivity and Specificity
1
2009
1691
0.010
 Why?
Mice
1
2000
14916
0.010
 Why?
Hemostatics
1
2003
47
0.010
 Why?
Random Allocation
1
2003
335
0.010
 Why?
Drug Resistance
1
2002
158
0.010
 Why?
Purpura
1
2001
13
0.010
 Why?
Wound Healing
1
2003
258
0.010
 Why?
Statistics as Topic
1
2002
294
0.010
 Why?
Blood Coagulation Tests
1
2001
57
0.010
 Why?
Angina Pectoris
1
2000
63
0.010
 Why?
Immunoblotting
2
1992
283
0.010
 Why?
Exanthema
1
2001
74
0.010
 Why?
Diarrhea
1
2001
173
0.010
 Why?
Mutation
1
1990
3350
0.010
 Why?
Confidence Intervals
1
2000
309
0.010
 Why?
Age Distribution
1
2000
339
0.010
 Why?
Probability
1
2000
291
0.010
 Why?
Young Adult
1
2014
10463
0.010
 Why?
Equipment Design
1
2001
508
0.010
 Why?
Sulfonamides
1
2001
445
0.010
 Why?
Odds Ratio
1
2000
954
0.010
 Why?
Hematocrit
1
1997
85
0.010
 Why?
Pain
1
2001
710
0.010
 Why?
Health Care Costs
1
1998
380
0.010
 Why?
Length of Stay
1
1998
949
0.010
 Why?
Disease Progression
1
2000
2387
0.010
 Why?
Ristocetin
1
1992
1
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
1992
28
0.010
 Why?
Fibrinolysin
1
1992
15
0.010
 Why?
Oligonucleotide Probes
1
1990
54
0.010
 Why?
Polymerase Chain Reaction
1
1990
994
0.000
 Why?
Amino Acids
1
1990
448
0.000
 Why?
Base Sequence
1
1990
2118
0.000
 Why?
Molecular Sequence Data
1
1990
2791
0.000
 Why?
DNA
1
1990
1351
0.000
 Why?
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (377) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)